Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Johnson and Johnson
McKesson
Harvard Business School
Medtronic

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Amlodipine Besylate And Benazepril Hydrochloride patents expire, and what generic alternatives are available?

Amlodipine Besylate And Benazepril Hydrochloride is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Inc, Lupin Pharms, Mylan, Par Pharm, Teva Pharms, Watson Labs, and Watson Labs Inc. and is included in twelve NDAs.

The generic ingredient in AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE is amlodipine besylate; benazepril hydrochloride. There are fifty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; benazepril hydrochloride profile page.

Summary for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Drug patent expirations by year for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Recent Clinical Trials for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Jiao Tong University School of MedicinePhase 4
Novartis PharmaceuticalsPhase 4
Dr. Reddy's Laboratories LimitedPhase 1

See all AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE clinical trials

Pharmacology for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

US Patents and Regulatory Information for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077179-001 May 18, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 079047-001 Jul 5, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 077890-003 Oct 14, 2010 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Express Scripts
McKesson
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.